RANKL-Based Osteoclastogenic Assays from Murine Bone Marrow Cells
Authors:
- 1 January 2014
- book chapter
- Published by Springer Nature
- Vol. 1130, 307-313
Abstract
Osteoclasts are the only cell type in the body to resorb bone. Osteoclasts play a critical role in physiologic and pathologic bone remodeling. Many genetic mouse models affect the skeleton by regulating osteoclast function directly or indirectly. This protocol describes a procedure for generating osteoclasts from mouse bone marrow cells using macrophage colony stimulating factor and receptor activator of NF-κB ligand.Keywords
This publication has 7 references indexed in Scilit:
- Osteoclast Culture and Resorption Assays2008
- NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1Journal of Biological Chemistry, 2007
- Systemic tumor necrosis factor α mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor α–transgenic miceArthritis & Rheumatism, 2004
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T CellsJournal of Biological Chemistry, 1997
- 1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow.Proceedings of the National Academy of Sciences, 1985
- Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells.Journal of Cell Biology, 1984